24 results
6-K
EX-99.2
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
, as soon as is reasonably practicable, appoint a qualified successor Rights Agent who shall be a stock transfer agent of national reputation … transfer agent of national reputation or the corporate trust department of an international commercial bank.
(e) The Rights Agent will cooperate
DRS
AMYT
Amryt Pharma Plc
19 Feb 20
Draft registration statement
12:00am
to delay or deny clearance for our products or result in product recalls that could harm our reputation, business and financial results.
The Acquisition … reputation and exposure to adverse publicity;
warnings on product labels;
withdrawal of clinical trial participants;
substantial monetary awards
F-1
AMYT
Amryt Pharma Plc
8 Jan 21
Registration statement (foreign)
4:58pm
regulatory authorities to delay or deny clearance for our products or result in product recalls that could harm our reputation, business and financial … claims may result in:
decreased demand or coverage for our products;
impairment of our business reputation and exposure to adverse publicity
424B4
AMYT
Amryt Pharma Plc
8 Jul 20
Prospectus supplement with pricing info
4:05pm
regulatory authorities to delay or deny clearance for our products or result in product recalls that could harm our reputation, business and financial … , product liability claims may result in:
decreased demand or coverage for our products;
impairment of our business reputation and exposure to adverse
F-1/A
AMYT
Amryt Pharma Plc
12 Jan 21
Registration statement (foreign) (amended)
12:00am
, the EMA or other regulatory authorities to delay or deny clearance for our products or result in product recalls that could harm our reputation, business … , product liability claims may result in:
decreased demand or coverage for our products;
impairment of our business reputation and exposure to adverse
DRS/A
6weq1 7vrul6gbev
29 May 20
Draft registration statement (amended)
12:00am
20-F
csi3unr fz8zl3n7x
30 Apr 21
Annual report (foreign)
12:53pm
DRS
x3p6fcavoujoym022s
18 Dec 20
Draft registration statement
12:00am
F-1/A
zwlt1vwcjwdmerp36nb5
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
xq7qd nlwjt
23 Jun 20
Registration statement (foreign)
5:21pm
424B4
frpy3im90 08a
14 Jan 21
Prospectus supplement with pricing info
9:30am
20-F
EX-2.7
8u2h1qbq zm
30 Apr 21
Annual report (foreign)
12:53pm
F-4
uv1r11rm f5t6sd1hvs6
15 Jun 21
Registration of securities (foreign)
12:00am
F-4/A
syuyeuqgff km1
29 Jun 21
Registration of securities (foreign) (amended)
9:29am
424B4
007au
20 May 22
Prospectus supplement with pricing info
5:06pm
424B3
gtgk2j0
1 Jul 21
Prospectus supplement
5:20pm
F-3
7uibp141
11 May 22
Shelf registration (foreign)
5:22pm